FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116926954> ?p ?o ?g. }

• W2116926954 endingPage "A161" @default.
• W2116926954 startingPage "A151" @default.
• W2116926954 abstract "India has the highest under-five death toll globally, approximately 20% of which is attributed to vaccine-preventable diseases. India's Universal Immunization Programme (UIP) is working both to increase immunization coverage and to introduce new vaccines. Here, we analyze the disease and financial burden alleviated across India's population (by wealth quintile, rural or urban area, and state) through increasing vaccination rates and introducing a rotavirus vaccine. We use IndiaSim, a simulated agent-based model (ABM) of the Indian population (including socio-economic characteristics and immunization status) and the health system to model three interventions. In the first intervention, a rotavirus vaccine is introduced at the current DPT3 immunization coverage level in India. In the second intervention, coverage of three doses of rotavirus and DPT and one dose of the measles vaccine are increased to 90% randomly across the population. In the third, we evaluate an increase in immunization coverage to 90% through targeted increases in rural and urban regions (across all states) that are below that level at baseline. For each intervention, we evaluate the disease and financial burden alleviated, costs incurred, and the cost per disability-adjusted life-year (DALY) averted. Baseline immunization coverage is low and has a large variance across population segments and regions. Targeting specific regions can approximately equate the rural and urban immunization rates. Introducing a rotavirus vaccine at the current DPT3 level (intervention one) averts 34.7 (95% uncertainty range [UR], 31.7–37.7) deaths and $215,569 (95% UR, $207,846–$223,292) out-of-pocket (OOP) expenditure per 100,000 under-five children. Increasing all immunization rates to 90% (intervention two) averts an additional 22.1 (95% UR, 18.6–25.7) deaths and $45,914 (95% UR, $37,909–$53,920) OOP expenditure. Scaling up immunization by targeting regions with low coverage (intervention three) averts a slightly higher number of deaths and OOP expenditure. The reduced burden of rotavirus diarrhea is the primary driver of the estimated health and economic benefits in all intervention scenarios. All three interventions are cost saving. Improving immunization coverage and the introduction of a rotavirus vaccine significantly alleviates disease and financial burden in Indian households. Population subgroups or regions with low existing immunization coverage benefit the most from the intervention. Increasing coverage by targeting those subgroups alleviates the burden more than simply increasing coverage in the population at large." @default.
• W2116926954 created "2016-06-24" @default.
• W2116926954 creator A5023199622 @default.
• W2116926954 creator A5031145973 @default.
• W2116926954 creator A5041643822 @default.
• W2116926954 creator A5066026593 @default.
• W2116926954 creator A5071690494 @default.
• W2116926954 creator A5088575114 @default.
• W2116926954 creator A5091541378 @default.
• W2116926954 date "2014-08-01" @default.
• W2116926954 modified "2023-10-01" @default.
• W2116926954 title "Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim" @default.
• W2116926954 cites W1968774184 @default.
• W2116926954 cites W1975886617 @default.
• W2116926954 cites W1977730005 @default.
• W2116926954 cites W1984523865 @default.
• W2116926954 cites W2003728556 @default.
• W2116926954 cites W2029086429 @default.
• W2116926954 cites W2033070545 @default.
• W2116926954 cites W2041645657 @default.
• W2116926954 cites W2042970866 @default.
• W2116926954 cites W2081569298 @default.
• W2116926954 cites W2086566281 @default.
• W2116926954 cites W2087429774 @default.
• W2116926954 cites W2094353560 @default.
• W2116926954 cites W2096394008 @default.
• W2116926954 cites W2100775497 @default.
• W2116926954 cites W2105025384 @default.
• W2116926954 cites W2113069496 @default.
• W2116926954 cites W2145659716 @default.
• W2116926954 cites W2153108001 @default.
• W2116926954 doi "https://doi.org/10.1016/j.vaccine.2014.04.080" @default.
• W2116926954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25091670" @default.
• W2116926954 hasPublicationYear "2014" @default.
• W2116926954 type Work @default.
• W2116926954 sameAs 2116926954 @default.
• W2116926954 citedByCount "34" @default.
• W2116926954 countsByYear W21169269542014 @default.
• W2116926954 countsByYear W21169269542015 @default.
• W2116926954 countsByYear W21169269542016 @default.
• W2116926954 countsByYear W21169269542017 @default.
• W2116926954 countsByYear W21169269542018 @default.
• W2116926954 countsByYear W21169269542019 @default.
• W2116926954 countsByYear W21169269542020 @default.
• W2116926954 countsByYear W21169269542021 @default.
• W2116926954 countsByYear W21169269542022 @default.
• W2116926954 countsByYear W21169269542023 @default.
• W2116926954 crossrefType "journal-article" @default.
• W2116926954 hasAuthorship W2116926954A5023199622 @default.
• W2116926954 hasAuthorship W2116926954A5031145973 @default.
• W2116926954 hasAuthorship W2116926954A5041643822 @default.
• W2116926954 hasAuthorship W2116926954A5066026593 @default.
• W2116926954 hasAuthorship W2116926954A5071690494 @default.
• W2116926954 hasAuthorship W2116926954A5088575114 @default.
• W2116926954 hasAuthorship W2116926954A5091541378 @default.
• W2116926954 hasBestOaLocation W21169269541 @default.
• W2116926954 hasConcept C118552586 @default.
• W2116926954 hasConcept C147483822 @default.
• W2116926954 hasConcept C203014093 @default.
• W2116926954 hasConcept C22070199 @default.
• W2116926954 hasConcept C2522874641 @default.
• W2116926954 hasConcept C27415008 @default.
• W2116926954 hasConcept C2776438120 @default.
• W2116926954 hasConcept C2777227250 @default.
• W2116926954 hasConcept C2780664029 @default.
• W2116926954 hasConcept C2780801004 @default.
• W2116926954 hasConcept C2781367151 @default.
• W2116926954 hasConcept C2908647359 @default.
• W2116926954 hasConcept C71924100 @default.
• W2116926954 hasConcept C99454951 @default.
• W2116926954 hasConceptScore W2116926954C118552586 @default.
• W2116926954 hasConceptScore W2116926954C147483822 @default.
• W2116926954 hasConceptScore W2116926954C203014093 @default.
• W2116926954 hasConceptScore W2116926954C22070199 @default.
• W2116926954 hasConceptScore W2116926954C2522874641 @default.
• W2116926954 hasConceptScore W2116926954C27415008 @default.
• W2116926954 hasConceptScore W2116926954C2776438120 @default.
• W2116926954 hasConceptScore W2116926954C2777227250 @default.
• W2116926954 hasConceptScore W2116926954C2780664029 @default.
• W2116926954 hasConceptScore W2116926954C2780801004 @default.
• W2116926954 hasConceptScore W2116926954C2781367151 @default.
• W2116926954 hasConceptScore W2116926954C2908647359 @default.
• W2116926954 hasConceptScore W2116926954C71924100 @default.
• W2116926954 hasConceptScore W2116926954C99454951 @default.
• W2116926954 hasFunder F4320306137 @default.
• W2116926954 hasFunder F4320332238 @default.
• W2116926954 hasLocation W21169269541 @default.
• W2116926954 hasLocation W21169269542 @default.
• W2116926954 hasLocation W21169269543 @default.
• W2116926954 hasOpenAccess W2116926954 @default.
• W2116926954 hasPrimaryLocation W21169269541 @default.
• W2116926954 hasRelatedWork W2027367339 @default.
• W2116926954 hasRelatedWork W2113069496 @default.
• W2116926954 hasRelatedWork W2351083769 @default.
• W2116926954 hasRelatedWork W2356932359 @default.
• W2116926954 hasRelatedWork W2367011401 @default.
• W2116926954 hasRelatedWork W2372338879 @default.
• W2116926954 hasRelatedWork W2378025613 @default.

• next